251 related articles for article (PubMed ID: 119858)
1. Consumption of C3 via the classical and alternative complement pathways by sera and synovial fluids from patients with rheumatoid arthritis.
Hunder GG; McDuffie FC; Clark RJ
J Clin Lab Immunol; 1979 Nov; 2(4):269-73. PubMed ID: 119858
[TBL] [Abstract][Full Text] [Related]
2. Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis.
Elson CJ; Carter SD; Cottrell BJ; Scott DG; Bacon PA; Wallington TB
Clin Exp Immunol; 1985 Feb; 59(2):285-92. PubMed ID: 3978872
[TBL] [Abstract][Full Text] [Related]
3. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. I. Activation of both the classical and the alternative pathways of guinea pig complement.
Inada K
Jpn J Exp Med; 1980 Feb; 50(1):13-21. PubMed ID: 6770130
[TBL] [Abstract][Full Text] [Related]
4. Activation of complement components C3 and factor B in synovial fluids.
Hunder GG; McDuffie FC; Mullen BJ
J Lab Clin Med; 1977 Jan; 89(1):160-71. PubMed ID: 830776
[TBL] [Abstract][Full Text] [Related]
5. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
6. [Complement (C3)-activating material in synovial fluid from patients with rheumatoid arthritis].
Stojan B
Z Rheumatol; 1981; 40(5):208-12. PubMed ID: 6914866
[TBL] [Abstract][Full Text] [Related]
7. Activation of classical pathway complement in chronic inflammation. Elevated levels of circulating C3d and C4d split products in rheumatoid arthritis and Crohn's disease.
Petersen NE; Elmgreen J; Teisner B; Svehag SE
Acta Med Scand; 1988; 223(6):557-60. PubMed ID: 3389208
[TBL] [Abstract][Full Text] [Related]
8. Detection and quantitation in plasma and synovial fluid of a fragment of human C4 with alpha mobility generated during the activation of the complement system.
Perrin LH; Shiraishi S; Stroud RM; Lambert PH
J Immunol; 1975 Jul; 115(1):32-5. PubMed ID: 1171140
[TBL] [Abstract][Full Text] [Related]
9. [Serum complement levels in patients with rheumatoid arthritis and vasculitis].
Tomooka K
Fukuoka Igaku Zasshi; 1989 Oct; 80(10):456-66. PubMed ID: 2613159
[TBL] [Abstract][Full Text] [Related]
10. Immune complex detection and complement activity in rheumatoid arthritis: a comparative study of a radioimmunoassay using monoclonal rheumatoid factor, gel diffusion techniques and C4 activity.
Halla JT; Volanakis JE; Hardin JG; Schrohenloher RE
Clin Exp Immunol; 1978 Nov; 34(2):226-34. PubMed ID: 737907
[TBL] [Abstract][Full Text] [Related]
11. [CH50, C3 and C4 in the serum and synovial fluid of rheumatoid arthritis patients].
Sheĭtanov I; Nikolov K; Petrova P
Vutr Boles; 1987; 26(4):66-70. PubMed ID: 3499707
[TBL] [Abstract][Full Text] [Related]
12. [Study of C3 and C4 complement components of synovial fluids in connective tissue diseases (author's transl)].
Böhm U; Merétey K; Falus A; Jancsó A; Bozsóky S
Allerg Immunol (Leipz); 1978; 24(3):167-74. PubMed ID: 152571
[TBL] [Abstract][Full Text] [Related]
13. [The complement system].
Lambert PH
Schweiz Med Wochenschr; 1975 Sep; 105(37):1180-4. PubMed ID: 1215899
[TBL] [Abstract][Full Text] [Related]
14. The complement fixing properties and class distribution of rheumatoid factors (antiglobulins) in rheumatoid arthritis and other diseases.
March RE; Reeback JS; Holborow EJ; Jones VE; Jacoby RK
Clin Exp Immunol; 1982 Jun; 48(3):555-60. PubMed ID: 6981473
[TBL] [Abstract][Full Text] [Related]
15. Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.
Verbrugh HA; Van Dijk WC; Peters R; Van Der Tol ME; Peterson PK; Verhoef J
Immunology; 1979 Mar; 36(3):391-7. PubMed ID: 108204
[TBL] [Abstract][Full Text] [Related]
16. The requirement of specific anticapsular IgG for killing of Haemophilus influenzae by the alternative pathway of complement activation.
Tarr PI; Hosea SW; Brown EJ; Schneerson R; Sutton A; Frank MM
J Immunol; 1982 Apr; 128(4):1772-5. PubMed ID: 6977569
[TBL] [Abstract][Full Text] [Related]
17. C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.
Whaley K; Schur PH; Ruddy S
J Clin Invest; 1976 Jun; 57(6):1554-63. PubMed ID: 819459
[TBL] [Abstract][Full Text] [Related]
18. Extracts of airborne grain dusts activate alternative and classical complement pathways.
Olenchock SA; Mull JC; Major PC
Ann Allergy; 1980 Jan; 44(1):23-8. PubMed ID: 6766283
[TBL] [Abstract][Full Text] [Related]
19. Killing of the S and Re forms of Salmonella minnesota via the classical pathway of complement activation in guinea-pig and human sera.
Clas F; Loos M
Immunology; 1980 Aug; 40(4):547-56. PubMed ID: 6776034
[TBL] [Abstract][Full Text] [Related]
20. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
Kozlov LV; Shibanova ED; Zinchenko AA
Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
